Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Novo Nordisk has begun selling Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump ...

Novo Nordisk lobbies to maintain Medicaid coverage for Wegovy Some states face financial strain from Wegovy's cost and demand Novo says obesity is a treatable disease, patients deserve access to care ...

(Bloomberg) -- Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...